theophylline

1
Reactions 1152 - 19 May 2007 S Theophylline Encephalopathy in a child treated with hypothermic therapy: case report A 4-year-old girl developed acute encephalopathy during treatment with theophylline for asthma and was successfully treated with hypothermic therapy. The girl received theophylline [dosage and duration of treatment not stated] and was admitted with status epilepticus and fever. The girl received IV diazepam, phenytoin and pentobarbital, but her convulsions persisted for over 90 minutes. On admission, she was diagnosed with acute encephalopathy which was thought might be associated with theophylline. Laboratory tests revealed hyperglycaemia (306 mg/dL), elevated serum ferritin levels (1280 ng/mL), hyperammonaemia (162 mg/dL), a serum theophylline concentration of 7.0 mg/dL and a decreased pyridoxal level of 3.3 ng/mL. On the third day, she had a creatine kinase level of 2675 U/L. CSF analysis revealed an interleukin-6 level of 92.7 pg/mL. EEG revealed high-voltage slow waves. She received mild hypothermic therapy, high-dose methylprednisolone and pyridoxal phosphate. On day 18, her consciousness recovered and single photon-emission CT (SPECT) revealed asymmetrical decreased perfusion at the frontal lobes and MRI showed mild atrophic changes in the cerebrum. By day 28, she could walk, but she did not speak and had an IQ test score of 16. Ten months after reaction onset, she had an IQ test score of 87 and SPECT showed improvement of cerebral perfusion. Author comment: "We suggest that mild hypothermic therapy in combination with methylprednisolone pulsetherapy and pyridoxal phosphate may be a candidate for the treatment of theophylline-related encephalopathy." Imataka G, et al. Theophylline-related encephalopathy in childhood: successful treatment with hypothermic therapy. Acta Neurologica Scandinavica Supplementum 115 (Suppl. 186): 79 abstr. e-6, 2007 [abstract] - Japan 801073969 1 Reactions 19 May 2007 No. 1152 0114-9954/10/1152-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: trinhhanh

Post on 20-Mar-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Theophylline

Reactions 1152 - 19 May 2007

STheophylline

Encephalopathy in a child treated with hypothermictherapy: case report

A 4-year-old girl developed acute encephalopathy duringtreatment with theophylline for asthma and was successfullytreated with hypothermic therapy.

The girl received theophylline [dosage and duration oftreatment not stated] and was admitted with status epilepticusand fever.

The girl received IV diazepam, phenytoin and pentobarbital,but her convulsions persisted for over 90 minutes. Onadmission, she was diagnosed with acute encephalopathywhich was thought might be associated with theophylline.Laboratory tests revealed hyperglycaemia (306 mg/dL),elevated serum ferritin levels (1280 ng/mL),hyperammonaemia (162 mg/dL), a serum theophyllineconcentration of 7.0 mg/dL and a decreased pyridoxal level of3.3 ng/mL. On the third day, she had a creatine kinase level of2675 U/L. CSF analysis revealed an interleukin-6 level of92.7 pg/mL. EEG revealed high-voltage slow waves. Shereceived mild hypothermic therapy, high-dosemethylprednisolone and pyridoxal phosphate. On day 18, herconsciousness recovered and single photon-emission CT(SPECT) revealed asymmetrical decreased perfusion at thefrontal lobes and MRI showed mild atrophic changes in thecerebrum. By day 28, she could walk, but she did not speakand had an IQ test score of 16. Ten months after reactiononset, she had an IQ test score of 87 and SPECT showedimprovement of cerebral perfusion.

Author comment: "We suggest that mild hypothermictherapy in combination with methylprednisolonepulsetherapy and pyridoxal phosphate may be a candidate forthe treatment of theophylline-related encephalopathy."Imataka G, et al. Theophylline-related encephalopathy in childhood: successfultreatment with hypothermic therapy. Acta Neurologica ScandinavicaSupplementum 115 (Suppl. 186): 79 abstr. e-6, 2007 [abstract] - Japan 801073969

1

Reactions 19 May 2007 No. 11520114-9954/10/1152-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved